Bayer CEO Outlines Action In Aftermath Of Ukraine Invasion

'Time For United And Decisive Political Action'

01 Mar 2022

A “shocked” Werner Baumann says that the German major is doing "everything in our power to support our colleagues and their families in Ukraine" following the Russian invasion, providing donations and emergency accommodation.

Bayer AG's annual press conference to discuss its performance in 2021, a year that saw substantial growth and a strengthening of the pharma pipeline, has unsurprisingly been dominated by Russia's invasion of Ukraine and the impact it is already having on the German group's business.

CEO Werner Baumann began by saying that "we too are certainly shocked by the events of the past few days...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

Executives On The Move: Three New CEOs And CFOs Among This Week’s Changes

06 Jun 2025

Recent moves in the industry include changes at the top at Mitsubishi Tanabe Pharma and MC2 Therapeutics, plus MindMed acquires chief financial officer from Longboard Pharma.

Europe’s Drugmakers Lament EU Pharma Package

05 Jun 2025

• By Kevin Grogan

EFPIA says reforms make the continent less attractive for innovative firms.

MetaVia Sees Obesity Opportunities Despite Challenging US Market

03 Jun 2025

• By Jung Won Shin

Despite new challenges related to obesity drug insurance coverage in the US, MetaVia's CEO is confident in the company's novel contender, which unlike rival GLP-1 therapies doesn’t require dose titration.